|
Volumn 4, Issue 6, 1996, Pages 549-554
|
The addition of dexfenfluramine to fluoxetine in the treatment of obesity: A randomized clinical trial
a a a a a |
Author keywords
Dexfenfluramine; Fluoxetine; Hyperlipemia; Obesity; Weight reduction
|
Indexed keywords
FENFLURAMINE;
FLUOXETINE;
LIPID;
SEROTONIN RECEPTOR AFFECTING AGENT;
SEROTONIN UPTAKE INHIBITOR;
ADULT;
AGED;
ARTICLE;
BLOOD;
BODY MASS;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG COMBINATION;
DRUG EFFECT;
FEMALE;
HUMAN;
MALE;
MIDDLE AGED;
MORBID OBESITY;
PATHOPHYSIOLOGY;
RANDOMIZED CONTROLLED TRIAL;
TREATMENT OUTCOME;
WEIGHT REDUCTION;
ADULT;
AGED;
BODY MASS INDEX;
DRUG THERAPY, COMBINATION;
FEMALE;
FENFLURAMINE;
FLUOXETINE;
HUMANS;
LIPIDS;
MALE;
MIDDLE AGED;
OBESITY, MORBID;
SEROTONIN AGENTS;
SEROTONIN UPTAKE INHIBITORS;
TREATMENT OUTCOME;
WEIGHT LOSS;
|
EID: 0030278088
PISSN: 10717323
EISSN: None
Source Type: Journal
DOI: 10.1002/j.1550-8528.1996.tb00268.x Document Type: Article |
Times cited : (23)
|
References (10)
|